Last reviewed · How we verify
CBD-THC-Piperine-PNL capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
CBD-THC-Piperine-PNL capsule (CBD-THC-Piperine-PNL capsule) — Hadassah Medical Organization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CBD-THC-Piperine-PNL capsule TARGET | CBD-THC-Piperine-PNL capsule | Hadassah Medical Organization | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CBD-THC-Piperine-PNL capsule CI watch — RSS
- CBD-THC-Piperine-PNL capsule CI watch — Atom
- CBD-THC-Piperine-PNL capsule CI watch — JSON
- CBD-THC-Piperine-PNL capsule alone — RSS
Cite this brief
Drug Landscape (2026). CBD-THC-Piperine-PNL capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/cbd-thc-piperine-pnl-capsule. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab